AbbVie (ABBV) Dividends Paid - Common (2013 - 2026)
AbbVie's (ABBV) quarterly Dividends Paid - Common came in at $3.1 billion in Q2 2026, up 5.5% year-over-year from $2.9 billion in Q2 2025, and down 0.52% quarter-over-quarter from $3.1 billion in Q1 2026.
Analysis
AbbVie (ABBV) Dividends Paid - Common (2013 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Dividends Paid - Common for 14 consecutive years, with $3.1 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Dividends Paid - Common rose 5.5% year-over-year to $3.1 billion in Q2 2026; TTM through Jun 2026 was $12.0 billion, a 5.64% increase from a year earlier, with the FY2025 full-year figure at $11.7 billion, up 5.73% from the prior year.
- Dividends Paid - Common was $3.1 billion for Q2 2026 at AbbVie, down from $3.1 billion in the prior quarter.
- Over five years, Dividends Paid - Common peaked at $3.1 billion in Q1 2026 and troughed at $2.5 billion in Q3 2022.
- A 5-year average of $2.7 billion and a median of $2.8 billion in 2024 frame the typical range for Dividends Paid - Common.
- Across the five-year window, Dividends Paid - Common rose 8.79% in 2022 and increased 4.17% in 2024, its largest moves.
- Over 5 years, Dividends Paid - Common stood at $2.5 billion in 2022, then grew by 4.79% to $2.6 billion in 2023, then increased by 4.8% to $2.8 billion in 2024, then climbed by 5.78% to $2.9 billion in 2025, then grew by 5.46% to $3.1 billion in 2026.
- The last three Dividends Paid - Common figures came in at $3.1 billion (Q2 2026), $3.1 billion (Q1 2026), and $2.9 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | -2.87 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 2.45 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 6.09 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Neurocrine Biosciences | 15.82 Bn | 15.43 Bn | 935.80 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.07 Bn |
| Mar 31, 2026 | 3.09 Bn |
| Dec 31, 2025 | 2.91 Bn |
| Sep 30, 2025 | 2.91 Bn |
| Jun 30, 2025 | 2.91 Bn |
| Mar 31, 2025 | 2.93 Bn |
| Dec 31, 2024 | 2.75 Bn |
| Sep 30, 2024 | 2.75 Bn |
| Jun 30, 2024 | 2.75 Bn |
| Mar 31, 2024 | 2.77 Bn |
| Dec 31, 2023 | 2.63 Bn |
| Sep 30, 2023 | 2.63 Bn |
| Jun 30, 2023 | 2.63 Bn |
| Mar 31, 2023 | 2.66 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Sep 30, 2022 | 2.50 Bn |
| Jun 30, 2022 | 2.51 Bn |
| Mar 31, 2022 | 2.53 Bn |
| Dec 31, 2021 | 2.31 Bn |
| Sep 30, 2021 | 2.32 Bn |